Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response

Overview of attention for article published in Arthritis Research & Therapy, December 2004

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 59 Dimensions

Readers on

mendeley: 46 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Predicting clinical response to treatment with a soluble tnf-antagonist or tnf, or a tnf…

Application EP-2192197-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.